The effect of 'universal test and treat' program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low income settings of Gurage zone, South Ethiopia
Autor: | Bereket Zeleke, Tadele Girum, Fitsum Bekele, Teha Shumbej, Fedila Yasin, Abebaw Wasie |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
lcsh:Immunologic diseases. Allergy
0301 basic medicine Adult Male Pediatrics medicine.medical_specialty Universal test and treat HIV treatment outcome HIV Infections Differed treatment HIV Testing 03 medical and health sciences 0302 clinical medicine Acquired immunodeficiency syndrome (AIDS) Virology medicine Humans Pharmacology (medical) 030212 general & internal medicine Poverty Survival analysis Proportional Hazards Models Retrospective Studies Proportional hazards model business.industry Incidence (epidemiology) Research Retrospective cohort study medicine.disease 030112 virology Survival Analysis Log-rank test Treatment Outcome Anti-Retroviral Agents Relative risk Cohort Patient survival Molecular Medicine Female Ethiopia Health Facilities lcsh:RC581-607 business |
Zdroj: | AIDS Research and Therapy AIDS Research and Therapy, Vol 17, Iss 1, Pp 1-9 (2020) |
ISSN: | 1742-6405 |
Popis: | Background Through universal “test and treat approach” (UTT) it is believed that HIV new infection and AIDS related death will be reduced at community level and through time HIV can be eliminated. With this assumption the UTT program was implemented since 2016. However, the effect of this program in terms of individual patient survival and treatment outcome was not assessed in relation to the pre-existing defer treatment approach. Objective To assess the effects of UTT program on HIV treatment outcomes and patient survival among a cohort of adult HIV infected patients taking antiretroviral treatment in Gurage zone health facilities. Methods Institution based retrospective cohort study was conducted in facilities providing HIV care and treatment. Eight years (2012–2019) HIV/AIDS treatment records were included in the study. Five hundred HIV/AIDS treatment records were randomly selected and reviewed. Data were abstracted using standardized checklist by trained health professionals; then it was cleaned, edited and entered by Epi info version 7 and analyzed by STATA. Cox model was built to estimate survival differences across different study variables. Results A total of 500 patients were followed for 1632.6 person-year (PY) of observation. The overall incidence density rate (IDR) of death in the cohort was 3 per-100-PY. It was significantly higher for differed treatment program, which is 3.8 per-100-PY compared to 2.4 per-100-PY in UTT program with a p value of 0.001. The relative risk of death among differed cases was 1.58 times higher than the UTT cases. The cumulative probability of survival at the end of 1st, 2nd, 3rd, and 4th years was 98%, 90.2%, 89.2% and 88% respectively with difference between groups. The log rank test and Kaplan–Meier survival curve indicated patients enrolled in the UTT program survived longer than patients enrolled in the differed treatment program (log rank X2 test = 4.1, p value = 0.04). Age, residence, base line CD4 count, program of enrolment, development of new OIS and treatment failure were predicted mortality from HIV infection. Conclusion Mortality was significantly reduced after UTT. Therefore, intervention to further reduce deaths has to focus on early initiation of treatment and strengthening UTT programs. |
Databáze: | OpenAIRE |
Externí odkaz: |